ATXI - Avenue Therapeutics

-

$undefined

N/A

(N/A)

Avenue Therapeutics NASDAQ:ATXI Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.

Location: 2 Gansevoort St Fl 9, New York, 10014-1667, US | Website: www.avenuetx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-2.886M

Cash

4.919M

Avg Qtr Burn

-2.147M

Short % of Float

1.18%

Insider Ownership

13.16%

Institutional Own.

8.13%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.